“Current Clinical Trials
Imetelstat is currently being tested in two clinical trials: IMbark, a Phase 2 trial in MF, and IMerge, a Phase 2/3 trial in MDS. These clinical trials are being conducted by Janssen Biotech, Inc. under the terms of an exclusive worldwide collaboration and license agreement. Information about the status of these clinical trials can be found on our Investors pages.” (https://www.geron.com/r-d/imetelstat/; obtained on 4-30-2018)
The author owns shares of Geron.
The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.
Louis DeCola, Jr. © 2018 The Hygiology Post ®